White House Expanding Access to Monoclonal Antibodies as Part of it’s 6-point Strategy to Combat COVID-19 Sep 9, 2021 On September 9, 2021, the White House announced it is expanding access to mAbs as part of it’s 6-point strategy to combat COVID-19. See the Improving Care for those with COVID-19 section on the White House COVID Plan webpage >>>